Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Cancer Institute Director's Consumer Liaison Group.
The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting.
Name of Committee: National Cancer Institute Director's Consumer Liaison Group.
Date: July 21, 2000.
Time: 2:30 p.m. to 4:30 p.m.
Agenda: To discuss the DCLG Team Leaders Reports on: Clinical Trials Participation, Advocacy Involvement, Communications Extraordinary Opportunity, NCI Brand, DCLG Operations, NCI Website, Quality Cancer Care Committee/Health Disparities, NCI Priorities and to discuss agenda topics for the upcoming September 2000 Advocates Summit Conference.
Place: Federal Building, Room 6C10, Bethesda, MD 20892, (Telephone Conference Call).
Contact Person: Elaine Lee, Acting Executive Secretary, Office of Liaison Activities, National Cancer Institute, National Institutes of Health, Federal Building, Room 6C10, Bethesda, MD 20892-2580, (301) 594-3194.
This notice is being published less than 15 days prior to the meeting due to scheduling conflicts.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)Start Signature
Dated: July 7, 2000.
LaVerne Y. Stringfield,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 00-17933 Filed 7-14-00; 8:45 am]
BILLING CODE 4140-01-M